These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10072815)
1. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma]. Ran R; Cao XA; Tian Y Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815 [TBL] [Abstract][Full Text] [Related]
2. [Homozygous deletion of CDKN2/p16 gene in lung cancers]. Su C; Ye Y; Cao X; Shan X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):315-7. PubMed ID: 10514540 [TBL] [Abstract][Full Text] [Related]
3. [p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers]. Wang G; Du C; Lin Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):5-8. PubMed ID: 9456359 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between tumor suppressor gene p16 and Rb and early diagnosis of lung cancers]. Ye Y; Su C; Wang D; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):537-41, 30. PubMed ID: 11832104 [TBL] [Abstract][Full Text] [Related]
5. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
6. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer. Panani AD; Maliaga K; Babanaraki A; Bellenis I Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395 [TBL] [Abstract][Full Text] [Related]
7. Relations of tumor suppressor gene p16 and RB to early diagnosis of lung cancer. Ye Y; Su C; Wang D; Guo W; Cheng X; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):885-9. PubMed ID: 11832187 [TBL] [Abstract][Full Text] [Related]
8. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771 [TBL] [Abstract][Full Text] [Related]
9. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer]. Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534 [TBL] [Abstract][Full Text] [Related]
10. [Alterations of FHIT gene and p16 gene in lung cancer and metastatic hilar lymph nodes]. Wang X; Sun Y; Li W Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):108-11. PubMed ID: 11776848 [TBL] [Abstract][Full Text] [Related]
11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837 [TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
15. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302 [TBL] [Abstract][Full Text] [Related]
16. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724 [TBL] [Abstract][Full Text] [Related]
17. [Mutation analysis of p16 gene in non-small cell lung carcinomas]. Fu S; Wang B; Huang C; Liu Q; Zhang G; Li P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):293-5. PubMed ID: 10514534 [TBL] [Abstract][Full Text] [Related]
18. Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray. Ye Y; Wang D; Su C; Rong T; Guo A Genet Mol Res; 2009 Dec; 8(4):1509-18. PubMed ID: 20082263 [TBL] [Abstract][Full Text] [Related]
19. [The efficacy of p16, p53 and p21 genes on the proliferation of lung cancer cells in vitro]. Wen G; Li J; Zou G; Fan X; Rao W Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):169-72. PubMed ID: 11812373 [TBL] [Abstract][Full Text] [Related]
20. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]